Objective.—To investigate the prevalence of medication overuse headache (MOH) in a group of children and adolescents seen for headache in a third-level center in Italy. Background.—Epidemiological studies indicate a prevalence of MOH in children and adolescents between 0.3 and 0.5%; no data are available for the Italian population. Methods.—We studied a group of first-seen children and adolescents (118 patients, 43.2% male and 56.8% female, mean age: 11.9 years). A detailed history was taken, using criteria defined by Olesen et al to assess the presence of MOH. Statistical correlations between demographic and diagnostic variables were assessed. Results.—Eleven (9.3%) of our patients presented MOH; in the group with chronic daily headache, the prevalence raised to 20.8%. At follow up, after introduction of a more rationale treatment, most patients improved, but 2 of them reported a worsening of their headache. Conclusions.—We believe that a strong warning regarding medication overuse in headache therapy is essential for pediatricians and neuropsychiatrists. Key words: medication overuse headache, chronic daily headache, child, adolescence, prevalence Abbreviations: CDH chronic daily headache, ICHD-II International Classification of Headache Disorders – 2nd Edition, MOH medication overuse headache
Orbitofrontal dysfunction and medication overuse in patients with migraine / B. Biagianti, L. Grazzi, O. Gambini, S. Usai, R. Muffatti, S. Scarone, G. Bussone. - In: HEADACHE. - ISSN 0017-8748. - 52:10(2012 Nov 12), pp. 1511-1519. [10.1111/j.1526-4610.2012.02277.x]
Orbitofrontal dysfunction and medication overuse in patients with migraine
B. Biagianti;O. Gambini;R. Muffatti;S. ScaronePenultimo
;
2012
Abstract
Objective.—To investigate the prevalence of medication overuse headache (MOH) in a group of children and adolescents seen for headache in a third-level center in Italy. Background.—Epidemiological studies indicate a prevalence of MOH in children and adolescents between 0.3 and 0.5%; no data are available for the Italian population. Methods.—We studied a group of first-seen children and adolescents (118 patients, 43.2% male and 56.8% female, mean age: 11.9 years). A detailed history was taken, using criteria defined by Olesen et al to assess the presence of MOH. Statistical correlations between demographic and diagnostic variables were assessed. Results.—Eleven (9.3%) of our patients presented MOH; in the group with chronic daily headache, the prevalence raised to 20.8%. At follow up, after introduction of a more rationale treatment, most patients improved, but 2 of them reported a worsening of their headache. Conclusions.—We believe that a strong warning regarding medication overuse in headache therapy is essential for pediatricians and neuropsychiatrists. Key words: medication overuse headache, chronic daily headache, child, adolescence, prevalence Abbreviations: CDH chronic daily headache, ICHD-II International Classification of Headache Disorders – 2nd Edition, MOH medication overuse headacheFile | Dimensione | Formato | |
---|---|---|---|
head2277.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
68.89 kB
Formato
Adobe PDF
|
68.89 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.